These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16320706)

  • 1. [Introduction to medical abzymology: the present and the prospect].
    Suchkov SV; Gabibov AG
    Vestn Ross Akad Med Nauk; 2005; (10):44-53. PubMed ID: 16320706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenomenon of DNA-abzyme cross-reactivity and its significance for the mechanisms of cytotoxicity and apoptosis].
    Suchkov SV; Gabibov AG; Gnuchev NV
    Ontogenez; 2001; 32(5):348-52. PubMed ID: 11605407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human catalytic RNA- and DNA-hydrolyzing antibodies.
    Nevinsky GA; Buneva VN
    J Immunol Methods; 2002 Nov; 269(1-2):235-49. PubMed ID: 12379364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenetic implications].
    Kalinina EV; Ponomarenko NA; Durova OM; Paleev FN; Vorob'ev II; Kekenadze NN; Shogenov ZS; Zemtsova ME; Gnuchev NV; Gabibov AG
    Ter Arkh; 2005; 77(9):65-70. PubMed ID: 16281493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural antibodies to nucleic acids.
    Buneva VN; Krasnorutskii MA; Nevinsky GA
    Biochemistry (Mosc); 2013 Feb; 78(2):127-43. PubMed ID: 23581984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies with enzymatic properties in human autoimmune diseases.
    Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M
    J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.
    Nevinsky GA; Buneva VN
    J Cell Mol Med; 2003; 7(3):265-76. PubMed ID: 14594551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catalytic antibodies or "abzymes"].
    Lacroix-Desmazes S; Bayry J; Kazatchkine MD; Kaveri SV
    Med Sci (Paris); 2003 May; 19(5):519-22. PubMed ID: 12836378
    [No Abstract]   [Full Text] [Related]  

  • 11. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis].
    Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of enzymatic properties of DNA-abzymes and human DNAses.
    Baranovskii AG; Odintsova ES; Buneva VN; Doronin BM; Nevinsky GA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1053-6. PubMed ID: 15560102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies.
    Gabibov AG; Kozyr AV; Kolesnikov AV
    Chem Immunol; 2000; 77():130-56. PubMed ID: 11706703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting antibodies as catalysts: potential therapeutic applications.
    Tellier C
    Transfus Clin Biol; 2002 Jan; 9(1):1-8. PubMed ID: 11889895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde.
    Belogurov A; Kozyr A; Ponomarenko N; Gabibov A
    Bioessays; 2009 Nov; 31(11):1161-71. PubMed ID: 19795406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural catalytic antibodies (abzymes) in normalcy and pathology.
    Nevinsky GA; Kanyshkova TG; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1245-55. PubMed ID: 11112840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic antibodies (abzymes) induced by stable transition-state analogs.
    Nevinsky GA; Semenov DV; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1233-44. PubMed ID: 11112839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents.
    Smirnov I; Belogurov A; Friboulet A; Masson P; Gabibov A; Renard PY
    Chem Biol Interact; 2013 Mar; 203(1):196-201. PubMed ID: 23123255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance?
    Kozyr AV; Gabibov AG
    Autoimmunity; 2009 May; 42(4):359-61. PubMed ID: 19811301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.